Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, by Product Type (Instruments and Reagents & Kits), by Technology (Helicase Dependent Amplification (HAD),  Nicking Enzyme Amplification Reaction (NEAR), Nucleic Acid Sequence-based Amplification (NASBNA), Transcription Medicated Amplification (TMA), Single Primer Isothermal Amplification (SPIA), and Loop-mediated Isothermal Amplification (LAMP)), by Application (Infectious Disease Diagnostics, Blood Screening, Others), by End User (Academic and Research Institutes, Diagnostic Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued at US$ 1,900.6 million in 2019 and is expected to exhibit a CAGR of 8.3% during the forecast period (2019 - 2027).

The rising development of user friendly and highly efficient products working on INAAT technology, by key players is expected to boost growth of the global isothermal nucleic acid amplification technology (INAAT) market. For instance, Genomtec is planning to launch the product Genomtech ID in December 2021, which is a handy, device that operates on the principle of isothermal nucleic acid amplification technology (INAAT). The company received a grant of US$ 2.17 Mn from the National Center for Research and Development (NCBR) in 2019, for research and development of the product. The device consist of a reaction card, on which the biological material is applied and the card is inserted in the device. After diagnosis, the result is displayed on the screen in 20 minutes. The advantages offered by the device include sample preparation step is eliminated, reaction time is reduced to 20 minutes as compared to the real time PCR and the cost of the device is less as compared to the other PCR models.

Genomtech ID has applications in diagnostic purpose, where pathogens such as viruses, bacteria, or fungi can be identified from biological materials (blood, sputum, swab, body fluids, saliva, urine, tissue and cerebrospinal fluid) in just 15 -20 minutes with a specificity close to 100%.

The increasing product and technology developments for DNA amplification is expected to fuel the global isothermal nucleic acid amplification technology (INAAT) market growth. For instance, in June 2019, researchers from Tokyo Institute of Technology, Abbott Japan Co., Ltd, and the University of Electro-Communications developed a new way of amplifying DNA, known as DNA L-TEAM (Low-temperature Amplification). This technique is used to amplify DNA segments and it works at body temperature (37°C/98.6°F).

Browse 33 Market Data Tables and 31 Figures spread through 177 Pages and in-depth TOC on "Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, by Product Type (Instruments and Reagents & Kits), by Technology (Helicase Dependent Amplification (HAD), Nicking Enzyme Amplification Reaction (NEAR), Nucleic Acid Sequence-based Amplification (NASBNA), Transcription Medicated Amplification (TMA), Single Primer Isothermal Amplification (SPIA), and Loop-mediated Isothermal Amplification (LAMP)), by Application (Infectious Disease Diagnostics, Blood Screening, Others), by End User (Academic and Research Institutes, Diagnostic Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2027”

To know the latest trends and insights related to Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, click the link below:

https://www.coherentmarketinsights.com/market-insight/isothermal-nucleic-acid-amplification-technology-inaat-market-2831

Key players in the market are focused on research and introduction of DNA amplification technology, which is expected to boost the global isothermal nucleic acid amplification technology market growth. For instance, in December 2019, Genomtec received Horizon 2020 SME phase I grant for Genomtec Tumor, a device which works on the principle of streamlined nucleic acid amplification technology (SNAAT), which uses photon based technology for heating the reaction mixture and amplify specific fragments of nucleic acid which are specific to cancer. Therefore, it can be used for the prescription of personalized therapy for the patients suffering from cancer and this may increase the global isothermal nucleic acid amplification technology market growth over the forecast period.

Moreover, isothermal nucleic acid amplification technology (INAAT) has diagnostic application. For instance, in February 2019, according to the World Health Organization (WHO) information, nucleic acid amplification tests are used for the detection of malaria infections as well, which include polymerase chain reaction (PCR) including quantitative or real-time polymerase chain reaction, loop mediated isothermal amplification (LAMP), and quantitative nucleic acid sequence-based amplification. Hence, usage of nucleic acid tests in detection of malaria is expected to support growth of the global isothermal nucleic acid amplification technology (INAAT) market.

Furthermore, increasing launch of new isothermal kit for molecular diagnosis of diseases is expected to propel the global isothermal nucleic acid amplification technology (INAAT) market growth. For instance, in January 2018, Mast Diagnostics launched new Isoplex DNA Lyo isothermal amplification kit. Isoplex DNA Lyo Kit is based on loop-mediated isothermal amplification (LAMP) technology. It is a rapid nucleic acid amplification method associated with polymerase chain reaction.

Key Takeaways:

  • The global isothermal nucleic acid amplification technology (INAAT) market is expected to exhibit a CAGR of 8.3% during the forecast period (2019-2027), owing to increasing product launch activities by key players. For instance, in October 2016, Arcis Biotechnology launched its DNA blood kit, which is used for in vitro diagnostic testing. This kit is also suitable for polymerase chain reaction (PCR). PCR is based on isothermal nucleic acid amplification technology.
  • Among regions, Europe is expected to witness significant growth in the global isothermal nucleic acid amplification technology (INAAT) market over the forecast period, owing to increasing launch of molecular diagnostics workflow. For instance, in April 2018, Altona Diagnostics GmbH launched new CE-IVD marked AltoStar Molecular Diagnostic Workflow. Under this workflow, company launched various CE-marked real-time polymerase chain reaction (PCR) kits such as Parvorvirus B19. AltoStar allows real-time PCR infectious disease testing comprising nucleic acid purification, assay setup as well as automated cycler programming for amplification and detection.
  • Major players operating in the global isothermal nucleic acid amplification technology (INAAT) market include Alere Inc., Becton, Dickinson & Company, BioHelix Corporation, BioMerieux Biotechnology Company, Hologic Gene-Probe, QIAGEN Company, Thermo Fisher Scientific, Inc., Lucigen Corporation, Quidel Corporation, and NuGEN
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner